COVID-19

News

AstraZeneca buys into startup RQ Bio's COVID antibodies

Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing deal with AstraZeneca for monoclonal antibodies intended to protect vulnerabl

Events

Partner Content

2nd Annual mRNA-Based Therapeutics Summit Europe

Accelerating platforms for mRNA vaccines

Digital

USAID on expanding digital health globally – part one

Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strength

Digital

Pfizer: Pharma needs a business strategy for a digital world

The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train an age of digital transformation.

News

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

COV-BOOST trial data show value of fourth dose

Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection than a third dose, particularly in the over-70s, according to the latest readout from the UK

News